REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Haw Par Corporation Limited (Singapore)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Museums, Historical Sites, and Similar Institutions
Secondary Activities: Securities and Commodity Exchanges | Real Estate
Full name: Haw Par Corporation Limited Profile Updated: March 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Haw Par Corporation Limited is a company based in Singapore, with its head office in Singapore. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on April 02, 2026. The total number of employees is currently 101 - 500 (2025). The latest financial highlights indicate a net sales revenue drop of 6.07% in 2025. During that time, Haw Par Corporation Limited’s total assets grew by 3.29%. The net profit margin of Haw Par Corporation Limited increased by 22.2% in 2025.

Headquarters
401 Commonwealth Drive, 03-03 Haw Par Technocentre
Singapore; Singapore; Postal Code: 149598

Contact Details: Purchase the Haw Par Corporation Limited report to view the information.

Website: http://www.hawpar.com

Basic Information
Total Employees:
Purchase the Haw Par Corporation Limited report to view the information.
Outstanding Shares:
Purchase the Haw Par Corporation Limited report to view the information.
Financial Auditors:
Purchase the Haw Par Corporation Limited report to view the information.
Incorporation Date:
April 02, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
28.42%
Purchase this report to view the information.
5.46%
Purchase this report to view the information.
0.26%
Purchase this report to view the information.
0.12%
Purchase this report to view the information.
0.067%
Subsidiaries
Haw Par Brothers International (H.K.) Limited (Hong Kong SAR, China)
100%
Haw Par Capital Pte Ltd
100%
Haw Par Centre Private Ltd
100%
Company Performance
Financial values in the chart are available after Haw Par Corporation Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
-6.07%▼
Total Operating Revenue
-44.73%▼
Operating Profit
-70.05%▼
EBITDA
-68.27%▼
Net Profit/Loss for the Period
16.29%▲
Total Assets
3.29%▲
Total Equity
3.44%▲
Operating Profit Margin
-69.06%▼
Net Profit Margin
22.2%▲
Return on Equity (ROE)
0.69%▲
Debt / Equity
146%▲
Quick Ratio
-731.03%▼
Cash Ratio
0.44%▲

Similar companies

Pfizer Asia Manufacturing Pte. Ltd.
 
Edwards Lifesciences (Singapore) Pte. Ltd.
Organon Asia Pacific Services Pte. Ltd.
 
Cardinal Health Singapore 225 Pte. Ltd.
Amgen Singapore Manufacturing Pte. Ltd.
 
Viatris Asia Pacific Pte. Ltd.
Roche Singapore Technical Operations, Pte. Ltd.
 
Abbvie Operations Singapore Pte. Ltd.
Glaxo Wellcome Manufacturing Pte Ltd
 
Strides Pharma Global Pte. Limited
Takeda Manufacturing Singapore Pte. Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo